Trasi, S.S. and Sashidharan, N. 2016. Itolizumab as the First Line of Treatment in Moderate to Severe Chronic Plaque Psoriasis- A Case Report. Asian Journal of Pharmaceutical and Clinical Research. 9, 2 (Mar. 2016), 12.